• About Us
    • What We Do
    • Our Story
    • Meet Our Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Careers
    • Australia
    • United States
  • Contact
  • About Us
    • What We Do
    • Our Story
    • Meet Our Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Careers
    • Australia
    • United States
  • Contact
Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study

Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study

Highlights Ellume submits Emergency Use Authorization to the U.S. Food and Drug Administration for the Ellume COVID-19 home test Clinical study demonstrated overall sensitivity of 95% and specificity of 97% Clinically validated for use in symptomatic and asymptomatic users ages 2 years and above Independently run, simulated home-use clinical study of 198 subjects Ellume is […]
Read More

ABC Radio “The Money” Interview with Ellume CEO, Dr Sean Parsons

29 October 2020, Richard Aedy Ellume Founder, CEO and Managing Director Dr Sean Parsons was interviewed by ABC Radio’s Richard Aedy on The Money program about how the company is scaling up its Brisbane manufacturing facilities as part of a US push to develop rapid COVID-19 testing technology. This interview originally appeared on ABC Radio […]
Read More
Ellume enlists Bosch Australia to automate manufacturing for high-performance COVID-19 Test

Ellume enlists Bosch Australia to automate manufacturing for high-performance COVID-19 Test

Highlights Ellume will collaborate with Bosch to create state-of-the-art automated production lines, to scale up manufacturing volumes of COVID-19 and other diagnostic tests. Bosch capabilities will build resilience and innovation into the local Ellume manufacturing processes. Bosch global automation and manufacturing know-how harnessed to ensure successful industrialisation of Ellume COVID-19 consumable test. New Ellume manufacturing […]
Read More

10 News First reports Ellume’s $42M NIH funding for rapid COVID test

8 October 2020, Samantha Butler Ellume Founder, CEO and Managing Director Dr Sean Parsons was recently interviewed by 10 News First Queensland’s Samantha Butler on the successful awarding of $42m from the US NIH to Ellume to scale up and fast track the production of its COVID-19 diagnostic tests. This interview originally appeared on 10 […]
Read More
Ellume awarded US$30M from US National Institutes of Health RADx initiative to accelerate development of rapid COVID-19 diagnostics

Ellume awarded US$30M from US National Institutes of Health RADx initiative to accelerate development of rapid COVID-19 diagnostics

Brisbane, Australia — 7 October 2020 Ellume, a leader in rapid digital diagnostics, today announced it was successfully awarded US$30million from the U.S. National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative to accelerate the clinical testing and manufacturing scale-up of the company’s COVID-19 antigen tests. Ellume’s core fluorescent immunoassay platform has been […]
Read More
Ellume announces high-performance test for active COVID-19 infection

Ellume announces high-performance test for active COVID-19 infection

Highlights New high-performance antigen test for active COVID-19 infection, developed by Ellume, provides accurate results in less than 15 minutes Builds on existing QIAGEN partnership to bring another test to market to join the rapid, reliable COVID antibody test as announced last month Easy to use; each device can process over 30 samples per hour, […]
Read More

ABC Radio Brisbane Interview with Ellume CEO, Dr Sean Parsons

31 August 2020, Kelly Higgins-Devine Ellume Founder, CEO and Managing Director Dr Sean Parsons was recently interviewed by ABC Brisbane Radio’s Kelly Higgins-Devine about how its innovative digital diagnostics are responding to the COVID-19 pandemic. This interview originally appeared on ABC Brisbane radio, “Mornings” program on 31st August 2020. Listen to the full Mornings episode […]
Read More
Brisbane biotech company to send millions of COVID-19 tests to US

Brisbane biotech company to send millions of COVID-19 tests to US

Digital diagnostics company Ellume has already shipped the first batch from the initial order of 900,000 test kits to the US, and will bring online in October a larger facility at Richlands that has a capacity of 15 million units a month.
Read More
Experts push for faster coronavirus tests to help Australia adapt to a new ‘COVID-normal’

Experts push for faster coronavirus tests to help Australia adapt to a new ‘COVID-normal’

Queensland-based digital diagnostics company Ellume has developed an antibody test that gives a result in less than 15 minutes and has already sold 900,000 tests to the United States.
Read More
Antibody test lab has designs on going global

Antibody test lab has designs on going global

30 August 2020, Robyn Ironside This article originally appeared in The Australian, print and online, on 30th August 2020. View the original article here on The Australian website. A Brisbane laboratory anticipating huge global demand for COVID tests is building a facility capable of producing 15 million tests a month. Ellume Health has already received […]
Read More
Page 3 of 512345
Recent Posts
  • QIAGEN receives U.S. FDA emergency use authorization for rapid portable SARS-CoV-2 antigen test
  • Push to allow at-home COVID tests in Australia
  • Why Aussie startup Ellume’s home-testing tech should help us in the COVID-19 recovery, but can’t
  • An Australian firm producing home COVID-19 tests for the US market has called on the federal government to reconsider its ban
  • Rapid COVID-19 Testing Device, Sunrise Interview with Ellume CEO Dr Sean Parsons
Archives
Categories
Business
Scroll
ellume logo white
Menu

Home
About Us
COVID-19 Response
Consumer Products
Professional Products
Global Public Health Solutions
Our Tech
News

Quick Links

Contact Us
Terms of Use
Privacy Policy
Whistleblower Policy

Some Ellume products are pending regulatory clearance. © Ellume Limited 2021
ABN 13 141 767 660